A High Court in the United Kingdom ruled it unlikely that minors suffering from gender dysphoria are able to give informed consent for hormone-blocking drugs. Ruth Institute Founder and President Dr. Jennifer Roback Morse, Ph.D., was greatly encouraged by this ruling.
“Keira Bell, one of the plaintiffs in the case, was given the drugs at age 16 after only three one-hour appointments. At 20, she had a double mastectomy. Now at 23, she’s in the process of de-transitioning.”
Bell said that, at the time, she believed the treatment would help her “achieve happiness.” When she began trying to reverse the process last year, she confessed,
“It was heartbreaking to realise I’d gone down the wrong path.”
Bell said the drugs “irreparably damaged” her body and likely left her sterile.
In a story for The Christian Post, Brandon Showalter reported that the court asked the Tavistock clinic to provide statistics on the percentage of patients on the autism spectrum. However, the clinic did not provide this data. The high court called this lack of data analysis and apparent lack of record keeping of children with autism, “surprising.”
“The government needs to take action to remove all transgender guidance and resources from schools and social service departments to safeguard children and prevent any further teaching of the ideology to children as fact.”
“The British ruling will help bring reason into a debate often clouded by emotion and the rhetoric of victimhood.”